Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bhalla

Showing results (61-70 of 189) with videos related to

Pageof 19
Sort By:
The Indian Journal of Medical Research|November 1, 1980
Calophyllolide--a new non-steroidal anti-inflammatory agentT N Bhalla, R C Saxena, S K Nigam, et al.
Indian Journal of Pediatrics|January 1, 1978
A study of blood glucose level in the newborn--from birth to 7 daysM Bhalla, J R Srivastava, J N Bhalla, et al.
Seminars in Hematology|May 16, 2002
Recent advances in Philadelphia chromosome-positive malignancies: the potential role of arsenic trioxideMichael E O'Dwyer, Paul La Rosée, Ramedivi Nimmanapalli, et al.
Cancer Research|February 24, 2001
Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levelsR Nimmanapalli, C L Perkins, M Orlando, et al.
Statistical Methods in Medical Research|February 28, 2025
A new cure model accounting for longitudinal data and flexible patterns of hazard ratios over timeCan Xie, Xuelin Huang, Ruosha Li, et al.
Catheterization and Cardiovascular Diagnosis|March 1, 1997
A single-step stent delivery, deployment, and expansion systemS Duvvuri, N Bhalla, A Shehadeh, et al.
Pharmacological Research Communications|March 1, 1983
Anti-inflammatory, analgesic and antiproteolytic activities of some novel thiadiazolesM Tandon, P Kumar, T N Bhalla, et al.
Indian Pediatrics|July 1, 1990
Prothrombin time in first week of life with special reference to vitamin K administrationG P Mathur, S Mathur, R Goenka, et al.
Oncotarget|December 13, 2012
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancerSreedhar Venkannagari, Warren Fiskus, Karissa Peth, et al.
Haematologica|October 5, 2013
Advances in myelofibrosis: a clinical case approachJohn O Mascarenhas, Attilio Orazi, Kapil N Bhalla, et al.
Pageof 19

Showing results (61-70 of 189) with videos related to

Sort By:
Pageof 19
The Indian Journal of Medical Research|November 1, 1980
Calophyllolide--a new non-steroidal anti-inflammatory agentT N Bhalla, R C Saxena, S K Nigam, et al.
Indian Journal of Pediatrics|January 1, 1978
A study of blood glucose level in the newborn--from birth to 7 daysM Bhalla, J R Srivastava, J N Bhalla, et al.
Seminars in Hematology|May 16, 2002
Recent advances in Philadelphia chromosome-positive malignancies: the potential role of arsenic trioxideMichael E O'Dwyer, Paul La Rosée, Ramedivi Nimmanapalli, et al.
Cancer Research|February 24, 2001
Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levelsR Nimmanapalli, C L Perkins, M Orlando, et al.
Statistical Methods in Medical Research|February 28, 2025
A new cure model accounting for longitudinal data and flexible patterns of hazard ratios over timeCan Xie, Xuelin Huang, Ruosha Li, et al.
Catheterization and Cardiovascular Diagnosis|March 1, 1997
A single-step stent delivery, deployment, and expansion systemS Duvvuri, N Bhalla, A Shehadeh, et al.
Pharmacological Research Communications|March 1, 1983
Anti-inflammatory, analgesic and antiproteolytic activities of some novel thiadiazolesM Tandon, P Kumar, T N Bhalla, et al.
Indian Pediatrics|July 1, 1990
Prothrombin time in first week of life with special reference to vitamin K administrationG P Mathur, S Mathur, R Goenka, et al.
Oncotarget|December 13, 2012
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancerSreedhar Venkannagari, Warren Fiskus, Karissa Peth, et al.
Haematologica|October 5, 2013
Advances in myelofibrosis: a clinical case approachJohn O Mascarenhas, Attilio Orazi, Kapil N Bhalla, et al.
Pageof 19